Related Experiment Videos
Type I-F CRISPR-Cas provides protection from DNA, but not RNA phages
Murat Buyukyoruk1, Blake Wiedenheft1
1Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717 USA.
Cell Discovery
|December 5, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Identification and structure determination of a type III-Bv CRISPR complex that post-translationally modifies an associated toxin.
Structure (London, England : 1993)·2026
Integrating mass spectrometry with Nanopore direct RNA sequencing for de novo modification profiling of bacteriophage MS2.
bioRxiv : the preprint server for biology·2026
A census of anti-CRISPR proteins reveals AcrIE9 and AcrIE13 as inhibitors of the Escherichia coli K12 type IE CRISPR-Cas system.
Proceedings of the National Academy of Sciences of the United States of America·2026
Structural basis of antiphage defence by an ATPase-associated reverse transcriptase.
Nature communications·2025
Structures reveal how the Cas1-2/3 integrase captures, delivers, and integrates foreign DNA into CRISPR loci.
bioRxiv : the preprint server for biology·2025
HMMR+ stromal cells drive human uterine development.
Cell discovery·2026
Responsibility without a map: defining oversight of automated result release in the medical laboratory.
Clinical chemistry and laboratory medicine·2026